Visit Dynavax Technologies

The company raised $125 million in its second public offering on the NASDAQ stock exchange under the ticker symbol of DVAX on July 21, 2015. A total of 4545455 shares were sold at $27.5 per share. After the offering, there was a total of 33,471,030 outstanding shares (excluding the over-allotment option) priced at $27.5 per share, valuing the company at $ 920.453325 million. The total proceeds, before expenses, to the company was $117.500012 million. The underwriters may also purchase up to an additional 681,818 shares from us at the public offering price, less underwriting discounts and commissions, within 30 days from the date of this prospectus to cover over-allotments.